Newsroom

Press Releases

Kythera Newsroom

2009 Archive

October 22, 2009
KYTHERA Biopharmaceuticals Announces Two Data Presentations on Its Novel Fat Reduction Drug at ASPS Meeting

October 2, 2009
Kythera Biopharmaceuticals Presents Positive Data From Two Phase 2 Studies With ATX-101

October 2, 2009
KYTHERA Biopharmaceuticals Presents Positive Data From Two Phase 2 Studies with ATX-101 - Study Results Demonstrated Statistically Significant Reduction in Patients' Unwanted Submental Fat

October 1, 2009
MEDIA ADVISORY — KYTHERA Biopharmaceuticals Announces Presentation Of Phase 2 Data On Novel Fat Reduction Drug At ASDS Meeting

September 15, 2009
KYTHERA Biopharmaceuticals Announces Initiation Of First-In-Human Trial For ATX-104 — A Light-Activated Facial Contouring Agent

June 1, 2009
KYTHERA Biopharmaceuticals To Participate In The Private Company Forum At The 30th Annual Goldman Sachs Global Healthcare Conference

March 24, 2009
KYTHERA Biopharmaceuticals, Inc. Selected To Present At Insideventure’s Debut Investor Conference, March 25-26, Santa Barbara, CA

February 18, 2009
KYTHERA Biopharmaceuticals Secures Additional $10M - Financing Follows Positive Phase II Data In Two Clinical Trials

January 23, 2009
Los Angeles Venture Association 6th Annual Awards Dinner Honors Elevation Partners’ Ted Meisel, 7 Entrepreneurs

January 6, 2009
KYTHERA Biopharmaceuticals Announces Positive Results from Two Phase 2 Studies with ATX-101 Demonstrating Reduction of Submental Fat

View Pipeline »

Submental Fat Reduction »